Related Experiment Video
Updated: Feb 8, 2026

In Silico Clinical Trials for Cardiovascular Disease
Published on: May 27, 2022
Cash incentives versus defaults for HIV testing: A randomized clinical trial
Juan Carlos C Montoy1, William H Dow2, Beth C Kaplan1
1Department of Emergency Medicine, University of California, San Francisco, San Francisco, California, United States of America.
Small cash incentives and default options significantly increased HIV test acceptance in a clinical trial. Combining these behavioral economics tools showed less than additive effects, suggesting careful consideration for implementation.
Area of Science:
- Behavioral Economics
- Public Health
- Clinical Trials
Background:
- Behavioral economics tools can improve health behaviors.
- Efficacy of different interventions for patient behavior is not well-established.
- Study focused on cash incentives and default options to increase HIV test acceptance.
Purpose of the Study:
- To test the influence of small cash incentives, defaults, and their combination on HIV test acceptance.
- To determine the relative efficacy and additive effects of behavioral economics interventions.
Main Methods:
- Randomized clinical trial in an urban emergency department.
- Patients aged 13-64 were cross-randomized to $0, $1, $5, $10 incentives and opt-in, active-choice, or opt-out defaults.
- Primary outcome: proportion of patients accepting an HIV test.
Main Results:
- Overall HIV test acceptance was 55.4%.
- $5 and $10 incentives increased acceptance by 10.5% and 15%, respectively.
- Opt-out defaults increased acceptance by 23.9%, significantly more than active-choice or opt-in.
Conclusions:
- Both small incentives and default options increase HIV test acceptance.
- Combined interventions had less than additive effects.
- Behavioral economics tools warrant consideration by clinicians and policymakers for public health interventions.
More Related Videos
03:26Author Spotlight: Advancements and Challenges in Surgical Treatments for Postamputation Pain
Published on: March 8, 2024
13:58Amplifying and Quantifying HIV-1 RNA in HIV Infected Individuals with Viral Loads Below the Limit of Detection by Standard Clinical Assays
Published on: September 26, 2011
Related Concept Videos
Clinical Trials
There are four phases in a clinical trial. A phase one...
Clinical Trials: Overview
Statistical Software for Data Analysis and Clinical Trials
Myocarditis II: Clinical Features and Diagnostic Tests
Pericarditis II: Clinical Features and Diagnostic Tests
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests